The Effect of Commercial Tests for Aneuploidy Screening Using Cell-free Fetal DNA on Rates of Invasive Testing in Clinical Practice

Authors

Adetola Louis-Jacques MD, Lehigh Valley Health NetworkFollow
Courtney R. Burans MS, CGC, Lehigh Valley Health NetworkFollow
Sarah Robinson, Lehigh Valley Health NetworkFollow
Elizabeth A. Schofield, Lehigh Valley Health NetworkFollow
Joanne Quiñones MD, MSCE, Lehigh Valley Health NetworkFollow
John C. Smulian MD, MPH, Lehigh Valley Health NetworkFollow
Meredith Rochon MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

4-28-2014

Comments

Copyright © Lehigh Valley Health Network

Published In/Presented At

Louis-Jacques, A., & Rochon, M. (2014, April 28). The effect of commercial tests for aneuploidy screening using cell-free fetal DNA on rates of invasive testing in clinical practice. Poster presented at: The 2014 Annual Clinical Meeting of the American College of Obstetricians and Gynecologists, Chicago, IL.

Disciplines

Medical Specialties | Medicine and Health Sciences | Obstetrics and Gynecology | Physical Sciences and Mathematics | Statistics and Probability

Department(s)

Department of Obstetrics and Gynecology, Department of Obstetrics and Gynecology Faculty, Department of Obstetrics and Gynecology Residents

Document Type

Poster